Voyageur Pharmaceuticals CEO Brent Willis joins Natalie Stoberman from the Proactive studios to discuss the successful completion of an environmental and geotechnical field work assessment at its Frances Creek project site through its 100% owned subsidiary Voyageur Industrial Minerals.
Willis says this milestone allows Voyageur Pharmaceuticals to mine and quarry their own minerals for their drugs, resulting in reduced costs and competitive pricing. Willis adds this milestone signifies progress towards production and positions Voyageur's Industrial Minerals division to compete effectively in the market.